Taken together, our findings strongly suggest that the disease etiology of GSD IV needs to be re-assessed from the perspective that GBE1 has a key role in cellular iron homeostasis, and that there must be a re-evaluation of current therapeutic strategies in the future. Here, GBE1 is linked to glycogen storage disease due to glycogen branching enzyme deficiency.